Uveitis Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global uveitis market is expected to grow at a CAGR of around 6.2% during 2025-2034. This report on global uveitis market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global uveitis market by segmenting the market based on treatment type, disease type, cause, distribution channel, and region. Also, detailed profiles of companies operating in the uveitis market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Growing R&D Activities • Increasing Awareness Levels • Increasing Number of Trials
Market Challenges
• Lack of Awareness
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Uveitis Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Uveitis Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Uveitis Market by Treatment Type
5.1. Introduction
5.2. Corticosteroids
5.3. Immunosuppressant
5.4. Monoclonal Antibodies
5.5. Cycloplegic Agents
5.6. Antibiotics
5.7. Antivirals
5.8. Antifungal
5.9. Analgesics
6. Global Uveitis Market by Disease Type
6.1. Introduction
6.2. Anterior Uveitis
6.3. Posterior Uveitis
6.4. Intermediate Uveitis
6.5. Panuveitis
7. Global Uveitis Market by Cause
7.1. Introduction
7.2. Infectious
7.3. Non-infectious
8. Global Uveitis Market by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Others
9. Global Uveitis Market by Region
9.1 Introduction
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Netherlands
9.2.8 Rest of the Europe
9.3 North America
9.3.1 United States
9.3.2 Canada
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 Indonesia
9.4.7 Rest of the Asia Pacific
9.5 Latin America
9.5.1 Mexico
9.5.2 Brazil
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 Turkey
9.6.3 Iran
9.6.4 Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1 Competitive Scenario
13.2 Company Profiles
13.2.1 AbbVie Inc.
13.2.2 Alimera Sciences Inc.
13.2.3 Bausch & Lomb Incorporated (Bausch Health)
13.2.4 Enzo Biochem Inc.
13.2.5 Eyegate Pharmaceuticals Inc.
13.2.6 Eyepoint Pharmaceuticals Inc.
13.2.7 Novartis AG
13.2.8 Regeneron Pharmaceuticals Inc.
13.2.9 Santen Pharmaceutical Co. Ltd.
List of Figures
Figure 1: Global Uveitis Market (in US$ Million), 2020-2024
Figure 2: Global Uveitis Market by Treatment Type, 2024
Figure 3: Global Uveitis Market by Disease Type, 2024
Figure 4: Global Uveitis Market by Cause, 2024
Figure 5: Global Uveitis Market by Distribution Channel, 2024
Figure 6: Global Uveitis Market by Region, 2024
Figure 7: Global Uveitis Market (in US$ Million), 2025-2034
Figure 8: Global Uveitis Market by Treatment Type (in %), 2024 & 2034
Figure 9: Global Corticosteroids Uveitis Market (in US$ Million), 2020-2024
Figure 10: Global Corticosteroids Uveitis Market (in US$ Million), 2025-2034
Figure 11: Global Immunosuppressant Uveitis Market (in US$ Million), 2020-2034
Figure 12: Global Immunosuppressant Uveitis Market (in US$ Million), 2025-2034
Figure 13: Global Monoclonal Antibodies Uveitis Market (in US$ Million), 2020-2034
Figure 14: Global Monoclonal Antibodies Uveitis Market (in US$ Million), 2025-2034
Figure 15: Global Cycloplegic Agents Uveitis Market (in US$ Million), 2020-2034
Figure 16: Global Cycloplegic Agents Uveitis Market (in US$ Million), 2025-2034
Figure 17: Global Antibiotics Uveitis Market (in US$ Million), 2020-2034
Figure 18: Global Antibiotics Uveitis Market (in US$ Million), 2025-2034
Figure 19: Global Antivirals Uveitis Market (in US$ Million), 2020-2034
Figure 20: Global Antivirals Uveitis Market (in US$ Million), 2025-2034
Figure 21: Global Antifungal Uveitis Market (in US$ Million), 2020-2034
Figure 22: Global Antifungal Uveitis Market (in US$ Million), 2025-2034
Figure 23: Global Analgesics Uveitis Market (in US$ Million), 2020-2034
Figure 24: Global Analgesics Uveitis Market (in US$ Million), 2025-2034
Figure 25: Global Uveitis Market by Disease Type (in %), 2024 & 2034
Figure 26: Global Anterior Uveitis Market (in US$ Million), 2020-2024
Figure 27: Global Anterior Uveitis Market (in US$ Million), 2025-2034
Figure 28: Global Posterior Uveitis Market (in US$ Million), 2020-2024
Figure 29: Global Posterior Uveitis Market (in US$ Million), 2025-2034
Figure 30: Global Intermediate Uveitis Market (in US$ Million), 2020-2024
Figure 31: Global Intermediate Uveitis Market (in US$ Million), 2025-2034
Figure 32: Global Panuveitis Uveitis Market (in US$ Million), 2020-2024
Figure 33: Global Panuveitis Uveitis Market (in US$ Million), 2025-2034
Figure 34: Global Uveitis Market by Cause (in %), 2024 & 2034
Figure 35: Global Infectious Uveitis Market (in US$ Million), 2020-2024
Figure 36: Global Infectious Uveitis Market (in US$ Million), 2025-2034
Figure 37: Global Non-Infectious Uveitis Market (in US$ Million), 2020-2034
Figure 38: Global Non-Infectious Uveitis Market (in US$ Million), 2025-2034
Figure 39: Global Uveitis Market by Distribution Channel (in %), 2024 & 2034
Figure 40: Global Hospital Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 41: Global Hospital Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 42: Global Retail Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 43: Global Retail Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 44: Global Online Pharmacies Uveitis Market (in US$ Million), 2020-2034
Figure 45: Global Online Pharmacies Uveitis Market (in US$ Million), 2025-2034
Figure 46: Global Others Uveitis Market (in US$ Million), 2020-2034
Figure 47: Global Others Uveitis Market (in US$ Million), 2025-2034
Figure 48: Global Uveitis Market by Region (in %), 2024 & 2034
Figure 49: Europe Uveitis Market (in US$ Million), 2020-2024
Figure 50: Europe Uveitis Market (in US$ Million), 2025-2034
Figure 51: Europe Uveitis Market by Country (in %), 2024 & 2034
Figure 52: Germany Uveitis Market (in US$ Million), 2020-2034
Figure 53: United Kingdom Uveitis Market (in US$ Million), 2020-2034
Figure 54: France Uveitis Market (in US$ Million), 2020-2034
Figure 55: Italy Uveitis Market (in US$ Million), 2020-2034
Figure 56: Spain Uveitis Market (in US$ Million), 2020-2034
Figure 57: Russia Uveitis Market (in US$ Million), 2020-2034
Figure 58: Netherlands Uveitis Market (in US$ Million), 2020-2034
Figure 59: North America Uveitis Market (in US$ Million), 2020-2024
Figure 60: North America Uveitis Market (in US$ Million), 2025-2034
Figure 61: North America Uveitis Market by Country (in %), 2024 & 2034
Figure 62: United States Uveitis Market (in US$ Million), 2020-2034
Figure 63: Canada Uveitis Market (in US$ Million), 2020-2034
Figure 64: Asia Pacific Uveitis Market (in US$ Million), 2020-2024
Figure 65: Asia Pacific Uveitis Market (in US$ Million), 2025-2034
Figure 66: Asia Pacific Uveitis Market by Country (in %), 2024 & 2034
Figure 67: China Uveitis Market (in US$ Million), 2020-2034
Figure 68: Japan Uveitis Market (in US$ Million), 2020-2034
Figure 69: India Uveitis Market (in US$ Million), 2020-2034
Figure 70: South Korea Uveitis Market (in US$ Million), 2020-2034
Figure 71: Australia Uveitis Market (in US$ Million), 2020-2034
Figure 72: Indonesia Uveitis Market (in US$ Million), 2020-2034
Figure 73: Latin America Uveitis Market (in US$ Million), 2020-2024
Figure 74: Latin America Uveitis Market (in US$ Million), 2025-2034
Figure 75: Latin America Uveitis Market by Country (in %), 2024 & 2034
Figure 76: Mexico Uveitis Market (in US$ Million), 2020-2034
Figure 77: Brazil Uveitis Market (in US$ Million), 2020-2034
Figure 78: Argentina Uveitis Market (in US$ Million), 2020-2034
Figure 79: Middle East & Africa Uveitis Market (in US$ Million), 2020-2024
Figure 80: Middle East & Africa Uveitis Market (in US$ Million), 2025-2034
Figure 81: Middle East & Africa Uveitis Market by Country (in %), 2024 & 2034
Figure 82: Saudi Arabia Uveitis Market (in US$ Million), 2020-2034
Figure 83: Turkey Uveitis Market (in US$ Million), 2020-2034
Figure 84: Iran Uveitis Market (in US$ Million), 2020-2034
Figure 85: Market Value Chain
List of Tables
Table 1: Global Uveitis Market Portraiture
Table 2: Global Uveitis Market by Treatment Type (in US$ Million), 2024 & 2034
Table 3: Global Uveitis Market by Disease Type (in US$ Million), 2024 & 2034
Table 4: Global Uveitis Market by Cause (in US$ Million), 2024 & 2034
Table 5: Global Uveitis Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 6: Global Uveitis Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Uveitis Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Uveitis Market by Country (in US$ Million), 2024 & 2034